Search

Your search keyword '"Pawankar, R."' showing total 655 results

Search Constraints

Start Over You searched for: Author "Pawankar, R." Remove constraint Author: "Pawankar, R."
655 results on '"Pawankar, R."'

Search Results

1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

2. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

3. Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis

4. Rhinitis associated with asthma is distinct from rhinitis alone:The ARIA-MeDALL hypothesis

5. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

6. The ARIA-MeDALL hypothesis

7. Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products

10. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

11. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

12. Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

14. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

15. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update – I – Plan and definitions

16. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy

17. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

18. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

19. WAO/EAACI.

20. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

21. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

23. Food allergy across the globe

24. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper (vol 12, 100080, 2020)

25. Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure – challenges and actions to be taken

27. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

28. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

29. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

30. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

31. Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

32. Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model

33. Toward personalization of asthma treatment according to trigger factors

34. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

35. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

36. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

37. International consensus on (ICON) pediatric asthma

39. Nonallergic Rhinitis-Identifying Gaps in Research: 986

40. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper

41. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

43. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen)

44. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

45. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

46. 2019 ARIA Care pathways for allergen immunotherapy

47. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

48. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy': AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Santé) POLLAR (Impact of Air POLLution on Asthma and Rhinitis) GARD Demonstration project

49. Changing the history of anaphylaxis mortality statistics through the World Health Organization's International Classification of Diseases–11

50. 2019 ARIA Care pathways for allergen immunotherapy

Catalog

Books, media, physical & digital resources